ELITechGroup Launches New SARS-CoV-2 PLUS ELITe MGB Kit
By LabMedica International staff writers
Posted on 17 Dec 2020
ELITech Group (Puteaux, France) has launched the CE-IVD marked SARS-CoV-2 PLUS ELITe MGB Kit that detects SARS-CoV-2, Flu A, Flu B, and RSV on the Sample-to Result-Platform ELITe InGenius and is available on major PCR thermocyclers as well.Posted on 17 Dec 2020
The kit detects the RNA of the two genomic regions “ORF8 gene” and “ORF1ab gene” for SARS-CoV-2, the RNA of the genomic region “Influenza A Matrix Gene” for Flu A, the RNA of genomic region “Influenza B Matrix Gene” for Flu B, the RNA of Nucleoprotein gene sequence of Respiratory Syncytial Virus for hRSV, and a human RNAse P. as an endogenous Internal Control to monitor the entire process from extraction to amplification.
Illustration
The Kit is CE-IVD marked, allowing the possibility of carrying out 96 tests on the ELITe InGenius platform, the sample-to-result solution, capable of analyzing up to 12 samples simultaneously in two hours and 30 minutes, and of re-analyzing them for additional investigation without the need for further extraction of genetic material. SARS-CoV-2 PLUS ELITe MGB Kit is compatible with the main Real Time PCR Platforms to meet the requirements of all laboratories involved in the fight against SARS-CoV-2 and to distinguish it from the most relevant seasonal respiratory viral pathogens.